For years, Pennington Biomedical Research Center has been instrumental in GLP-1 drug research, ensuring that these treatments are not only effective but also safe for people across the globe
In patients with MASLD and established CVD, GLP-1-based therapies are strongly supported as a cornerstone treatment addressing both hepatic and cardiometabolic disease burden simultaneously
The FDA has approved Rybelsus to help reduce the risk of major cardiovascular events such as stroke, heart attack, or death in adults who have type 2 diabetes and who are at high risk for these events
Then this second one after upping dose to 1mg was early, but heavier and smelling than usual." u/TownTechnical7785 Others report going months without a cycle after starting the drug, before their periods eventually returned
PPIs should be used at the lowest effective dose for the shortest duration necessary, as long-term use has been associated with (though not proven to cause) potential effects including nutrient malabsorption, increased infection risk, and bone health concerns